LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 19 10 2018
revised: 19 03 2019
accepted: 20 03 2019
pubmed: 27 3 2019
medline: 6 2 2020
entrez: 27 3 2019
Statut: ppublish

Résumé

Pulmonary hypertension (PH) is characterized by a thickening of the distal pulmonary arteries caused by medial hypertrophy, intimal proliferation and vascular fibrosis. Low density lipoprotein receptor-related protein 1 (LRP1) maintains vascular homeostasis by mediating endocytosis of numerous ligands and by initiating and regulating signaling pathways. Here, we demonstrate the increased levels of LRP1 protein in the lungs of idiopathic pulmonary arterial hypertension (IPAH) patients, hypoxia-exposed mice, and monocrotaline-treated rats. Platelet-derived growth factor (PDGF)-BB upregulated LRP1 expression in pulmonary artery smooth muscle cells (PASMC). This effect was reversed by the PDGF-BB neutralizing antibody or the PDGF receptor antagonist. Depletion of LRP1 decreased proliferation of donor and IPAH PASMC in a β1-integrin-dependent manner. Furthermore, LRP1 silencing attenuated the expression of fibronectin and collagen I and increased the levels of α-smooth muscle actin and myocardin in donor, but not in IPAH, PASMC. In addition, smooth muscle cell (SMC)-specific LRP1 knockout augmented α-SMA expression in pulmonary vessels and reduced SMC proliferation in 3D ex vivo murine lung tissue cultures. In conclusion, our results indicate that LRP1 promotes the dedifferentiation of PASMC from a contractile to a synthetic phenotype thus suggesting its contribution to vascular remodeling in PH.

Identifiants

pubmed: 30910704
pii: S0925-4439(19)30086-9
doi: 10.1016/j.bbadis.2019.03.012
pii:
doi:

Substances chimiques

ACTA2 protein, human 0
Actins 0
Antibodies, Neutralizing 0
Collagen Type I 0
Fibronectins 0
Integrin beta1 0
LRP1 protein, human 0
Low Density Lipoprotein Receptor-Related Protein-1 0
Nuclear Proteins 0
RNA, Small Interfering 0
Trans-Activators 0
myocardin 0
Becaplermin 1B56C968OA
Monocrotaline 73077K8HYV
Receptors, Platelet-Derived Growth Factor EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1604-1616

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Marius M Zucker (MM)

Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany.

Lukasz Wujak (L)

Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany.

Anna Gungl (A)

Ludwig Boltzmann Institute for Lung Vascular Research, Medical University Graz, Graz, Austria.

Miroslava Didiasova (M)

Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany.

Djuro Kosanovic (D)

Department of Internal Medicine, Universities of Giessen and Marburg Lung Center, Giessen, Germany; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Aleksandar Petrovic (A)

Department of Internal Medicine, Universities of Giessen and Marburg Lung Center, Giessen, Germany.

Walter Klepetko (W)

Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.

Ralph T Schermuly (RT)

Department of Internal Medicine, Universities of Giessen and Marburg Lung Center, Giessen, Germany.

Grazyna Kwapiszewska (G)

Ludwig Boltzmann Institute for Lung Vascular Research, Medical University Graz, Graz, Austria.

Liliana Schaefer (L)

Goethe University, School of Medicine, Frankfurt am Main, Germany.

Malgorzata Wygrecka (M)

Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany. Electronic address: malgorzata.wygrecka@innere.med.uni-giessen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH